Screener
Roivant Sciences ROIV Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $77.09M-18.7% | $44.53M-52.6% | $91.94M-7.2% | $102.19M-17.2% | $94.79M-98.3% | ||
| $2.59B-20.6% | $2.87B+32.3% | $3.05B-3.3% | $3.15B-8.1% | $3.26B— | ||
| $4.74B+2.7% | $5.17B+3.3% | $4.66B-13.1% | $4.51B-22.2% | $4.62B-23.1% | ||
| $11.32M-23.8% | $11.99M-0.6% | $13.45M-0.9% | $25.67M+87.7% | $14.87M-16.7% | ||
| $5.31B+5.4% | $5.71B+5.0% | $5.23B-9.8% | $5.06B-18.4% | $5.03B-22.5% | ||
| $25.08M+117% | $18M-24.0% | $13.29M-43.9% | $15.06M-40.0% | $11.55M-58.4% | ||
| $283.6M+149% | $281.24M+88.2% | $151.96M+7.4% | $133.86M-75.9% | $113.87M-47.1% | ||
| $0-100% | $0-100% | $251.14M-2.0% | $257.14M-58.9% | $216.7M-64.0% | ||
| 7B0.0% | 7B— | 7B0.0% | 7B0.0% | 7B0.0% | ||
| -$900.35M-185% | -$501.81M-532% | -$695M-251% | -$429.11M-208% | -$315.59M-147% | ||
| $4.23B-2.6% | $4.53B-3.4% | $4.27B-17.7% | $4.36B-15.3% | $4.35B-20.0% | ||
| $5.31B+5.4% | $5.71B+5.0% | $5.23B-9.8% | $5.06B-18.4% | $5.03B-22.5% |
FAQ
- What are Roivant Sciences's total assets?
- Roivant Sciences (ROIV) holds $5.3B in total assets, up 5.4% year over year.
- How much debt does Roivant Sciences have?
- Roivant Sciences carries $107.2M in total debt against $4.2B of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Roivant Sciences have?
- Roivant Sciences holds $77.1M in cash and equivalents.
- Can Roivant Sciences cover its short-term obligations?
- Its current ratio is 16.72 — current assets exceed current liabilities.
- Where does Roivant Sciences's balance sheet data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
